169 related articles for article (PubMed ID: 23566552)
1. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.
Karlsson L; Tuominen L; Huotarinen A; Leppämäki S; Sihvola E; Helin S; Sipilä M; Tani P; Hirvonen J; Hietala J; Karlsson H
Psychiatry Res; 2013 May; 212(2):164-5. PubMed ID: 23566552
[TBL] [Abstract][Full Text] [Related]
2. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
[TBL] [Abstract][Full Text] [Related]
3. Abnormal serotonin transporter availability in the brains of adults with conduct disorder.
Chang C; Gau SS; Huang WS; Shiue CY; Yeh CB
J Formos Med Assoc; 2017 Jun; 116(6):469-475. PubMed ID: 27771175
[TBL] [Abstract][Full Text] [Related]
4. A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM.
Gourand F; Emond P; Bergström JP; Takano A; Gulyás B; Guilloteau D; Barré L; Halldin C
Nucl Med Biol; 2014 Jul; 41(6):501-6. PubMed ID: 24857865
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in brain serotonin transporter availability in panic disorder.
Maron E; Tõru I; Hirvonen J; Tuominen L; Lumme V; Vasar V; Shlik J; Nutt DJ; Helin S; Någren K; Tiihonen J; Hietala J
J Psychopharmacol; 2011 Jul; 25(7):952-9. PubMed ID: 21148024
[TBL] [Abstract][Full Text] [Related]
6. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
Frick A; Åhs F; Engman J; Jonasson M; Alaie I; Björkstrand J; Frans Ö; Faria V; Linnman C; Appel L; Wahlstedt K; Lubberink M; Fredrikson M; Furmark T
JAMA Psychiatry; 2015 Aug; 72(8):794-802. PubMed ID: 26083190
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
[TBL] [Abstract][Full Text] [Related]
8. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.
Ding YS; Naganawa M; Gallezot JD; Nabulsi N; Lin SF; Ropchan J; Weinzimmer D; McCarthy TJ; Carson RE; Huang Y; Laruelle M
Neuroimage; 2014 Feb; 86():164-71. PubMed ID: 23933039
[TBL] [Abstract][Full Text] [Related]
9. Brain dopamine transporter levels in treatment and drug naïve adults with ADHD.
Volkow ND; Wang GJ; Newcorn J; Fowler JS; Telang F; Solanto MV; Logan J; Wong C; Ma Y; Swanson JM; Schulz K; Pradhan K
Neuroimage; 2007 Feb; 34(3):1182-90. PubMed ID: 17126039
[TBL] [Abstract][Full Text] [Related]
10. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
[TBL] [Abstract][Full Text] [Related]
11. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320
[TBL] [Abstract][Full Text] [Related]
12. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.
Krause J
Expert Rev Neurother; 2008 Apr; 8(4):611-25. PubMed ID: 18416663
[TBL] [Abstract][Full Text] [Related]
13. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS
Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910
[TBL] [Abstract][Full Text] [Related]
14. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
[TBL] [Abstract][Full Text] [Related]
15. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
Lundberg J; Odano I; Olsson H; Halldin C; Farde L
J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
[TBL] [Abstract][Full Text] [Related]
16. Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [
Majuri J; Joutsa J; Johansson J; Voon V; Parkkola R; Alho H; Arponen E; Kaasinen V
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1281-1288. PubMed ID: 29032922
[TBL] [Abstract][Full Text] [Related]
17. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
[TBL] [Abstract][Full Text] [Related]
18. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
[TBL] [Abstract][Full Text] [Related]
19. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
20. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort.
Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Cloninger CR; Raitakari O; Hietala J; Keltikangas-Järvinen L
Psychol Med; 2013 Apr; 43(4):881-94. PubMed ID: 22850434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
